| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2012-04-19 | SNG001 (inhaled interferon beta) | protection of asthmatic patients from respiratory virus infections | 2 | Synairgen (UK) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
| 2012-04-16 | AIC316 | genital herpes | 2 | Aicuris (Germany) | Infectious diseases |
| 2012-04-11 | omigapil | congenital muscular dystrophy |
1 | Santhera Pharmaceuticals (Switzerland) and EndoStem Consortium | Neuromuscular diseases - Rare diseases - Genetic diseases |
| 2012-04-11 | WX-554 | solid tumours | 1b-2 | Wilex (Germany) | Cancer - Oncology |
| 2012-04-05 | ZALTRAP® (aflibercept) | metastatic androgen-independent prostate cancer |
3 | Sanofi (France) Regeneron Pharmaceuticals (USA) | Cancer Oncology |
| 2012-04-05 | Zaltrap® (aflibercept) | first-line treatment of metastatic androgen-independent prostate cancer |
3 | Sanofi (France) Regeneron Pharmaceuticals (USA) | Cancer Oncology |
| 2012-04-04 | buparlisib (BKM120) | breast cancer | 2-3 | Novartis (Switzerland) | Cancer - Oncology |
| 2012-04-03 | albiglutide | type 2 diabetes | 3 | GSK (UK) | Metabolic diseases |
| 2012-04-02 | QVA149 (indacaterol 110 mcg/glycopyrronium bromide 50 mcg) | chronic obstructive pulmonary disease (COPD) |
3 | Novartis (Switzerland) | Respiratory diseases |
| 2012-04-02 | dolutegravir | naive adults with HIV-1 infection | 3 | ViiV Healthcare (UK-USA) Shionogi (Japan) | Infectious diseases |
| 2012-04-02 | Letermovir (AIC246) | prevention of HCMV (human cytomegalovirus) disease |
2b | Aicuris (Germany) | Infectious diseases |
| 2012-03-30 | SPD476, MMX® mesalamine | diverticulitis |
3 | Shire (UK-USA) | Digestive diseases |
| 2012-03-29 | PNB02 | schizophrenia | PharmaNeuroBoost (Belgium) | CNS diseases - Mental diseases | |
| 2012-03-29 | Kynamro® (mipomersen) | familial hypercholesterolemia |
3 | Genzyme (USA - MA), a Sanofi company (France) | Cardiovascular diseases - Genetic diseases |
| 2012-03-28 | Glybera® (alipogene tiparvovec) | lipoprotein lipase deficiency (LPLD) |
Amsterdam Molecular Therapeutics (The Netherlands) | Genetic diseases - Rare diseases | |
| 2012-03-27 | Glivec® (imatinib) | Gastrointestinal stromal tumors (GIST) | 3 | Novartis (Switzerland) | Cancer Oncology |
| 2012-03-26 | Xarelto® (rivaroxaban) | prevention of venous thromboembolism (VTE) in patients with acute symptomatic pulmonary embolism (PE) | 3 | Bayer (Germany) | Cardiovascular diseases |
| 2012-03-26 | REGN727/SAR236553 | primary hypercholesterolemia | 2 | Sanofi (France) Regeneron Pharmaceuticals (USA) | Cardiovascular diseases - Metabolic diseases |
| 2012-03-22 | trastuzumab (biosimilar product) | breast cancer gastric cancer |
1 | Synthon (The Netherlands) | Cancer - Oncology |
| 2012-03-20 | TMX-101 | non-muscle invasive bladder cancer (NMIBC) |
1-2 | Telormedix (Switzerland) | Cancer Oncology |
